The Critical Choice of Animal Models in Nanomedicine Safety Assessment: A Lesson Learned From Hemoglobin-Based Oxygen Carriers

Por Peter Bedőcs, Peter Bedőcs, Peter Bedőcs, János Szebeni, János Szebeni, János Szebeni
Publicado em 2020-10-01

Pseudo-anaphylaxis to PEGylated nanomedicines in a porcine model

Por Janos Szebeni, Gergely Kozma, Tamas Meszaros, Rudolf Urbanics
Publicado em 2020-08-01

Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro

Por Barry W. Neun, Yechezkel Barenholz, Janos Szebeni, Marina A. Dobrovolskaia
Publicado em 2018-07-01

Infusion Reactions Associated with the Medical Application of Monoclonal Antibodies: The Role of Complement Activation and Possibility of Inhibition by Factor H

Por Tamás Fülöp, Tamás Mészáros, Gergely Tibor Kozma, János Szebeni, Mihály Józsi
Publicado em 2018-03-01

Human serum albumin nanoparticles loaded with phthalocyanine dyes for potential use in photodynamic therapy of atherosclerotic plaques

Por Shubhadeep Banerjee, Jayeeta Sengupta, Ana Isabel Aljarilla, Francesca Setaro, Petri Makinen, LinPing Wu, Lari Holappa, Andres de la Escosura, Chiara Martinelli, Panagiotis Trohopoulos, Seppo Ylä-Herttuala, Rudolf Urbanics, Janos Szebeni, Tomas Torres, Silke Krol